Editorial · 2014
Review articlePublished 2014
BIOEQUIVALENCE STUDY: OVERVIEW
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While manufacturing generic drugs, the drug companies use the same active ingredients and, they have the same risks and benefits as their brand name likeness. Also, generic drugs have the same quality, strength, purity and stability as brand name drugs. The generic drugs are less expensive as compared to branded drugs as generic manufacturers do not have the investment costs of the developer of a new drug. New drugs are generally developed under patent protection. Bioequivalence is based on rate and extent, but rate and extent is depending on the absorption. Absorption is depending on drug dissolution, permeability and solubility. Firstly permeability and solubility related to biopharmaceutical classification system discovered by Gordon Amidon et al. in 1995. Bio analysis carried out with help of LC/MS and use of Solid phase extraction, Liquid/Liquid extraction, Protein precipitation
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 14 Feb 2019
Biopharmaceutics Classification System (BCS) Based Biowaiver Studies of Lenalidomide Capsules (25 mg) andndash; An Alternative to In vivo Bioequivalence Studies for Generic Oncology Drug Products
Research article · 2019
Biopharmaceutics Classification System (BCS) Based Biowaiver Studies of Lenalidomide Capsules (25 mg) – An Alternative to In vivo Bioequivalence Studies for Generic Oncology Drug Products
Research article · 31 Oct 2015
Biopharmaceutics classification system- basis for waiver of in-vivobioavailability and bioequivalence studies
Article · 28 Nov 2013
BIOAVAILABILITY AND BIOEQUIVALENCE STUDY IN CORRELATION OF BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) AND POSSIBLE MODIFICATION
More from this journal
The newest in Journal of Pharmaceutical and Scientific Innovation.
Article · 1 Nov 2024
Advanced Techniques for Dynamic Power Reduction in SRAM Circuits: A Physics-Based Approach
Article · 22 Feb 2024
PHARMACIST KNOWLEDGE IN THE TREATMENT AND THERAPEUTIC EDUCATION OF ASTHMA
Article · 30 Dec 2023
Authentication of Authorized Trading Partners in Pharmaceutical Drug Serialization and Traceability
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical and Scientific Innovation
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Balkrishana D. Tiwari”
- BylineArticles whose byline prints “Omkar N. Shikare”
- BylineArticles whose byline prints “Amruta M. Sontakke”
